
Please try another search
Cinclus Pharma Holding AB (publ), a clinical-stage pharmaceutical company, develops small molecules for the treatment of gastric acid-related diseases in China. The company’s lead product is linaprazan glurate, a potassium-competitive acid blocker that has completed Phase II clinical trial to treat gastroesophageal reflux disease. It also develops linaprazan glurate with antibiotics, which is in pre-clinical trial for the treatment of peptic ulcer bacteria Helicobacter pylori (H. pylori). Cinclus Pharma Holding AB (publ) was founded in 2014 and is headquartered in Stockholm, Sweden.
Name | Age | Since | Title |
---|---|---|---|
Wenche Rolfsen Sandsborg | 73 | 2016 | Independent Director |
Anders Ohberg | 45 | 2016 | Independent Director |
Lennart Hansson | 69 | 2014 | Co-founder & Chairman of the Board |
Peter Unge | 74 | 2014 | Co-founder & Director |
Nina Rawal | 46 | 2022 | Independent Director |
Helena Levander | 68 | 2021 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review